Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 239, pseudogene (RN7SL239P)
- Target
- RN7SL239P
- Molecular classification
- Pseudogene, non-coding RNA (ncRNA), Signal recognition particle-related fragment
01
Overview
RN7SL239P (RNA, 7SL, cytoplasmic 239, pseudogene) is a member of the family of pseudogenes derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP) in eukaryotes. Pseudogenes are generally non-functional gene copies or fragments that may arise by duplication or retrotransposition and lack protein-coding ability. In rare cases, pseudogenes may exert biological effects through regulation of RNA stability, miRNA binding, or other RNA-mediated mechanisms; however, RN7SL239P itself has not been shown to have any such function. Its primary clinical relevance is as a marker in genomics studies rather than as a therapeutic target. The functional 7SL RNA is essential for cotranslational protein targeting to the endoplasmic reticulum, but pseudogene copies like RN7SL239P do not contribute to these processes[1][4][5].
- Other names
- RN7SL239PRNA, 7SL, cytoplasmic 239, pseudogene
02
Mechanism of action
None known
03
Biological functions
No known direct biological function (pseudogene)Parental molecule (7SL RNA) is involved in SRP-mediated protein targeting, translation elongation arrest, and interacts with SRP proteins
04
Disease associations
No specific disease role established for RN7SL239PGeneral pseudogene functions (from other examples) can include RNA decoy (miRNA sponging) or post-transcriptional regulation
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 239, pseudogene (RN7SL239P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 239, pseudogene (RN7SL239P).